Voloridge Investment Management’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.08M | Buy |
162,315
+18,091
| +13% | +$789K | 0.03% | 655 |
|
|
2025
Q1 | $3.95M | Sell |
144,224
-3,014
| -2% | -$82.5K | 0.01% | 838 |
|
|
2024
Q4 | $5.92M | Sell |
147,238
-87,533
| -37% | -$3.52M | 0.02% | 726 |
|
|
2024
Q3 | $11.1M | Sell |
234,771
-38,748
| -14% | -$1.83M | 0.04% | 555 |
|
|
2024
Q2 | $8.16M | Buy |
273,519
+6,005
| +2% | +$179K | 0.03% | 619 |
|
|
2024
Q1 | $10.8M | Buy |
267,514
+25,716
| +11% | +$1.03M | 0.04% | 476 |
|
|
2023
Q4 | $6.16M | Buy |
241,798
+114,983
| +91% | +$2.93M | 0.02% | 574 |
|
|
2023
Q3 | $1.76M | Sell |
126,815
-88,392
| -41% | -$1.23M | 0.01% | 957 |
|
|
2023
Q2 | $4.95M | Sell |
215,207
-36,154
| -14% | -$831K | 0.02% | 674 |
|
|
2023
Q1 | $7.45M | Buy |
251,361
+111,473
| +80% | +$3.3M | 0.04% | 548 |
|
|
2022
Q4 | $3.49M | Sell |
139,888
-43,831
| -24% | -$1.09M | 0.02% | 784 |
|
|
2022
Q3 | $4M | Buy |
183,719
+11,447
| +7% | +$249K | 0.02% | 731 |
|
|
2022
Q2 | $3.39M | Buy |
+172,272
| New | +$3.39M | 0.02% | 817 |
|
|
2021
Q3 | – | Sell |
-48,460
| Closed | -$2.35M | – | 1758 |
|
|
2021
Q2 | $2.35M | Sell |
48,460
-50,905
| -51% | -$2.47M | 0.02% | 932 |
|
|
2021
Q1 | $3.86M | Buy |
+99,365
| New | +$3.86M | 0.03% | 607 |
|